219 related articles for article (PubMed ID: 33101238)
21. [Detection of enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Shanghai, 2002].
Yang ZH; Zhu QR; Li XZ; Wang XH; Wang JS; Hu JY; Tang W; Cui AL
Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):648-52. PubMed ID: 16191294
[TBL] [Abstract][Full Text] [Related]
22. Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry.
Ku Z; Ye X; Shi J; Wang X; Liu Q; Huang Z
J Virol; 2015 Dec; 89(23):12084-95. PubMed ID: 26401034
[TBL] [Abstract][Full Text] [Related]
23. A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles.
Chen J; Zhang C; Zhou Y; Zhang X; Shen C; Ye X; Jiang W; Huang Z; Cong Y
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093091
[TBL] [Abstract][Full Text] [Related]
24. Human transbodies to VP40 inhibit cellular egress of Ebola virus-like particles.
Teimoori S; Seesuay W; Jittavisutthikul S; Chaisri U; Sookrung N; Densumite J; Saelim N; Chulanetra M; Maneewatch S; Chaicumpa W
Biochem Biophys Res Commun; 2016 Oct; 479(2):245-252. PubMed ID: 27638305
[TBL] [Abstract][Full Text] [Related]
25. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
26. Fibronectin Facilitates Enterovirus 71 Infection by Mediating Viral Entry.
He QQ; Ren S; Xia ZC; Cheng ZK; Peng NF; Zhu Y
J Virol; 2018 May; 92(9):. PubMed ID: 29467312
[TBL] [Abstract][Full Text] [Related]
27. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease.
Tsou YL; Lin YW; Shao HY; Yu SL; Wu SR; Lin HY; Liu CC; Huang C; Chong P; Chow YH
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003692. PubMed ID: 25855976
[TBL] [Abstract][Full Text] [Related]
28. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Ningbo, China, 2008-2011.
Ni H; Yi B; Yin J; Fang T; He T; Du Y; Wang J; Zhang H; Xie L; Ding Y; Gu W; Zhang S; Han Y; Dong H; Su T; Xu G; Cao G
J Clin Virol; 2012 Aug; 54(4):342-8. PubMed ID: 22652041
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
30. The VP1 structural protein of enterovirus 71 interacts with human ornithine decarboxylase and gene trap ankyrin repeat.
Yeo WM; Chow VT
Microb Pathog; 2007 Apr; 42(4):129-37. PubMed ID: 17276651
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Coxsackievirus A6- and Enterovirus 71-Associated Hand Foot and Mouth Disease in Beijing, China, from 2013 to 2015.
Li J; Sun Y; Du Y; Yan Y; Huo D; Liu Y; Peng X; Yang Y; Liu F; Lin C; Liang Z; Jia L; Chen L; Wang Q; He Y
Front Microbiol; 2016; 7():391. PubMed ID: 27065963
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a novel monoclonal antibody reactive against the N-terminal region of Enterovirus 71 VP1 capsid protein.
Lim XF; Jia Q; Chow VT; Kwang J
J Virol Methods; 2013 Mar; 188(1-2):76-82. PubMed ID: 23219932
[TBL] [Abstract][Full Text] [Related]
33. Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand.
Lerdsamran H; Prasertsopon J; Mungaomklang A; Klinmalai C; Noisumdaeng P; Sangsiriwut K; Tassaneetrithep B; Guntapong R; Iamsirithaworn S; Puthavathana P
Virol J; 2018 Oct; 15(1):158. PubMed ID: 30326914
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies for diagnosis of enterovirus 71.
Xu L; Huang KJ; Ho TS; Liu CC; Lee YR; Lin CY; Shiuan D; Jiang XH
Monoclon Antib Immunodiagn Immunother; 2013 Dec; 32(6):386-94. PubMed ID: 24328741
[TBL] [Abstract][Full Text] [Related]
35. Engineered Human Monoclonal scFv to Receptor Binding Domain of
Densumite J; Phanthong S; Seesuay W; Sookrung N; Chaisri U; Chaicumpa W
Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34064480
[TBL] [Abstract][Full Text] [Related]
36.
Caine EA; Osorio JE
J Virol; 2017 Mar; 91(5):. PubMed ID: 27974562
[TBL] [Abstract][Full Text] [Related]
37. [Sequence and antigenicity analysis for VP4s of EV71 strains isolated from Children in Beijing].
Li YY; Zhu RN; Qian Y; Deng J; Sun Y; Wang F; Zhao LQ; Liu LY
Bing Du Xue Bao; 2011 May; 27(3):207-14. PubMed ID: 21774244
[TBL] [Abstract][Full Text] [Related]
38. The surveillance of the epidemiological and serotype characteristics of hand, foot, mouth disease in Neijiang city, China, 2010-2017: A retrospective study.
Li J; Yang Z; Wang Z; Xu Y; Luo S; Yu X; Liu J; Zhou Y; Tong W; Zeng P
PLoS One; 2019; 14(6):e0217474. PubMed ID: 31170178
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice.
Caine EA; Fuchs J; Das SC; Partidos CD; Osorio JE
Viruses; 2015 Nov; 7(11):5919-32. PubMed ID: 26593938
[TBL] [Abstract][Full Text] [Related]
40. Enterovirus 71 infection and vaccines.
Yi EJ; Shin YJ; Kim JH; Kim TG; Chang SY
Clin Exp Vaccine Res; 2017 Jan; 6(1):4-14. PubMed ID: 28168168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]